Table 2.
Neoadjuvant therapy and response, n (%)
| Neoadjuvant therapy | n = 36 |
| Clinical response | |
| PR | 18 (50) |
| SD | 18 (50) |
| Mandard grade | |
| 1 | 3 (8.3) |
| 2 | 4 (11.1) |
| 3 | 4 (11.1) |
| 4 | 3 (8.3) |
| 5 | 22 (61.1) |
PR: Partial remission; SD: Stable disease.
Neoadjuvant therapy and response, n (%)
| Neoadjuvant therapy | n = 36 |
| Clinical response | |
| PR | 18 (50) |
| SD | 18 (50) |
| Mandard grade | |
| 1 | 3 (8.3) |
| 2 | 4 (11.1) |
| 3 | 4 (11.1) |
| 4 | 3 (8.3) |
| 5 | 22 (61.1) |
PR: Partial remission; SD: Stable disease.